Pope Leo early-stage adenocarcinoma is a reminder that lung nodules often cause no symptoms and that people who never smoked can get lung cancer.
|Articles|May 29, 2018
10 Ways to Improve HEDIS® Reporting and Quality of Care for Health Plan Members
We’ve detailed 10 proven ways all health plans can put into practice now to improve scores this HEDIS® season.
Advertisement
HEDIS® scores matter. Typically, health plans invest countless hours and resources to increase their HEDIS® scores.
The most successful health plans are using a better way – advanced analytics to:
- Enhance collaboration between the plan, providers and members
- Target resources effectively to improve outcomes
In a new white paper, we’ve detailed the blueprint these health plans are using – so you can, too.
Download 10 Ways to Improve HEDIS® Reporting and Quality of Care for Members today. Get started tomorrow.
Download Supplement
Advertisement
Related to this article
Young-onset lung cancer often strikes nonsmokers, and current screening based on smoking is not likely to find it, says Singhi, an assistant professor at UT MD Anderson Cancer Center in Houston. New risk-based screening, liquid biopsies, and breath tests aim earlier detection.
Rex Hoffman, M.D., MBA, says physician shortages and burnout are the most underestimated pressures on health system.
Rex Hoffman, M.D., MBA, of Providence Holy Cross walks through a CMO’s day in a hospital that often runs 85% to 100% full, from safety huddles to discharges.
On average, caregivers want to see their children with ADHD fall asleep 30 minutes faster, but the best sleep treatments average approximately 20 minutes, a new survey study found.
Research findings presented at CHEST meeting show COPD hospital readmission drops with discharge checklists and navigation. Other research suggests targeting readmission prevention efforts on patents discharged to post-acute facilities.
As the pharmacist pipeline tightens, leaders from UC Davis Health, UCSF Health, and Sutter Health say financial sustainability now depends as much on capacity as on cost.
GLP-1 use in adults 65 and older with MASLD was linked to a 45% lower risk of death, and a 28% lower risk of hepatic decompensation, a new Houston Methodist Research Institute study shows.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Rex Hoffman, M.D., on physician burnout and collaborative leadership | HSES 2026
2
GLP-1 therapy tied to lower mortality and liver decompensation in older adults with MASLD
3
Preventing hospital readmissions among patients with COPD. Here are some ideas on how to do that | CHEST 2026
4
Algia Pharma completes investigational drug toxicology study for non-opioid acute pain regimen AlgiaPak
5